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Currently, there are two major conceptual frameworks for the term “frailty”: (a) physical frailty,
capturing representative signs and symptoms (fatigue, low activity, weakness, weight loss, and slow
gait) of community-dwelling older adults that are most vulnerable to adverse health outcomes;
(b) deficit accumulation frailty, identifying the most vulnerable older adults through cumulative
dysmetabolic, chronic comorbidities. The two frameworks are interconnected and have a common
denominator, which is advanced vulnerability, a generally held term capturing the essence of age-
related decline. Despite being a widely acknowledged concept in global health, its translation to the
general population health and health service delivery, planning, and utilization is in factual terms
often not thoroughly pursued.
It has been assessed that decreases in the mortality rates have largely plateaued and many
individuals spend longer lives in poor health conditions, often struggling with socially driven
conditions such as “chronic” drug use or abuse. The recent plague of COVID-19 infection has
(re) confirmed that underlying, hidden, forms of frailty can unmask under critical conditions.
These variable forms of frailty, although predominant in the older subjects, are not exclusive to
this population. Single or coexisting clinical manifestations of human organs and systems (e.g.,
complicated diabetes, dysmetabolic, neurodegenerative, cardiovascular conditions, myopathies,
obesity, sarcopenia, rheumatic diseases, hypogonadism, fragility fractures, and osteomalacia) can
determine a variety of outcomes ranging from asymptomatic, paucisymptomatic up to lethal.
Therefore, diagnosing one or more already acclaimed frailty conditions can be too simplistic and
reductionist. Instead, to precociously identify those who in their lifetime are likely to develop a
certain degree of frailty, both age- and non-age-related, appears a more comprehensive and useful
task. This means going beyond the orthogeriatric concept of frailty or, in other terms, going from
regional to global frailty.
Dysmobility syndrome summarizes a cluster of coexisting conditions, such as osteoporosis,
sarcopenia, obesity (sarcopenic and not), as well as other fragility fracture risk factors, that
determine a higher risk for falls and fractures (1), representing a typical age-related condition of
vulnerability. Currently, it is well known that most of the fragility fractures occur in people with
DXA-assessed bone mineral density values in the osteopenic area, probably because the quality
of their bones is deteriorated or has never been adequately built since childhood to adolescence
for various reasons. If those subjects should sustain falls and/or are also sarcopenic, their bone
frailty can be unmasked. Sarcopenia is largely undiagnosed in clinical care, but it remains linked
to substantial fracture and fall risk. Metabolic syndrome represents a cluster of not necessarily
age-related conditions that occur together and determine a higher risk for cardiovascular heart
diseases, type 2 diabetes, increased blood pressure, excess body fat around the waist, and mixed
dyslipidemia. This is a seemingly distinct entity from the dysmobility syndrome. However, the
common denominators of the two syndromes are impaired energy balance, either in terms of its
generation or dissipation/transformation, and low-physical activity levels. In the recent past, several
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studies, especially in animal models, have suggested that the
skeleton is not only a “simple” calcium and phosphate deposit,
responsive to calciotropic hormones, rather an actor playing
an important role in energy metabolism through hormonal
networks, such as adipokines, insulin/insulin-like growth
factor 1, and carboxylated/under carboxylated osteocalcin
ratio pathways (2), together with other organs involved in the
metabolic control. Osteoblasts, myocytes, and adipocytes have
common cellular origins from the mesenchymal stem cells,
and this makes the hypothesis that the skeleton has a role in
energy metabolism unsurprising. A combination of low bone
and muscle mass, poor skeletal quality, low-muscle function,
and relatively high-fat mass, also together with other factors,
could better screen the progression toward general and/or
single-, multiregional frailty and disability. However, it is not
always clear if this combination represents the starting or the
arrival point or whether they are just an epiphenomenon of a
generic frailty syndrome. Recognition of a progression toward
a low-physical activity level status, not necessarily age-related,
secondary to metabolic and/or dysmobility syndrome or their
combination, unifying osteoporosis, sarcopenia, obesity and
diabetes, and cardiovascular risk, brings the focus back to a
holistic view in which the patient is seen as a whole, and not
just to his/her bones, fat, or lean mass separately. However, this
holistic approach remains virtual in many cases. In addition,
focusing upon “intrinsic capacity” (3–5) for the identification
of individuals who may benefit from interventions, as well as
for clinical outcome measures, can reorient public health and
clinical practice away from the disease-orientated approach
toward a more effective person-centered approach based on the
functional evaluation, which will identify earlier opportunities
for intervention. This should overcome the traditional approach
FIGURE 1 | Towards a more comprehensive concept of “global frailty”.
by different specialists with segmented and not necessarily
communicating paths, often associated with fractioning of
clinical information and communication gaps between the
various specialists that ultimately lead to a disrupted continuum
of care.
Given such limitations, we reckon that a circular path
approach might be presented with more advantages. A common
multidisciplinary diagnostic-clinical-therapeutic management of
patients that allows findings from the endocrinologist, bone
specialist, cardiologist, and rheumatologist to flow to the PMR
specialist to address global function (bone, muscle, and fat mass)
more effectively (6). The PMR specialist circulates responses
of the patient to rehabilitation treatment back to the other
colleagues to optimize pharmacological therapies, in line with
the general principles of precision medicine. Such a circular
and personalized approach could provide us with a larger
therapeutic “armamentarium” for preventing functional decline
and minimizing disability starting from the younger ages than in
a traditional geriatric rehabilitation approach. This implies also
the need and the importance to accurately investigate the possible
existence of a family history of the single/combined/generalized
frailty syndrome. Consequently, we also suggest creating
composite scores considering low bone and muscle mass and
quality, low-lean mass, previous history of falls, slow-gait speed,
low-grip strength, high-fat mass, dysmetabolic conditions, and
levels of physical activity, similar to the existing fracture risk
calculators, to boost the effectiveness of rehabilitation programs.
This would precociously identify the subject at risk for entering
a condition of low-physical activity level, as also the combination
of factors to predict adverse musculoskeletal and dysmetabolic
outcomes. Therefore, a “multidisciplinary” effort must be made
to try obtaining a cumulative frailty score, considering the
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various existing algorithms to define susceptibility to develop
or worsen a frailty condition (e.g., algorithms Framingham,
SCORE30, and ASSIGN for the cardiovascular risk; algorithms
Diabetes Population Risk Tool and QDiabetes for the risks
connected to diabetes; and algorithms FRAX, Qfracture, and
Galvan for the fragility fracture risk) (7). Efforts should
be aimed at identifying new global, combinate, and risk
algorithms enabling the creation of score ranges that allow
for a real stratification of cumulative frailty risk. An early,
multidisciplinary approach to decrease the global risk of frailty
could be implemented, possibly creating appropriate machine
learning approaches. Metabolic and dysmobility syndromes
may provide an example of how reaching out of our comfort
zone of habitual rehabilitation protocols, promoting synergic
actions with other specialized medical branches, and creating
“Low-physical activity level Units” that aim to go beyond
the orthogeriatric units operating already in various national
health systems, in a perspective of personalized, person-centered
rehabilitation medicine based on the evaluation of individual
intrinsic capacity, potentially increasing the overall and cost-
benefit effectiveness of our programs (Figure 1). In this wake,
the International Classification of Functioning, Disability and
Health can be a useful tool to help profiling patients with a low
level of physical activity for various conditions and identifying
key factors associated with participation in community-based
physical activity/rehabilitation.
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